Pharmalot

Pharmalot By Damian Garde

Pharmalittle: Trump promises a Covid-19 vaccine in 2020; WHO’s grand experiment is faltering

Pharmalot By Ed Silverman

Employers are planning how to blunt the cost of gene therapies, pricey new specialty drugs

Pharmalot By Ed Silverman

Pharmalittle: Trump launches a crusade against the FDA; Europe signs Covid-19 vaccine deal with AstraZeneca

Pharmalot By Ed Silverman

Catalyst takes its fight over a rare disease drug to Canada, suing the country’s regulator

Pharmalot By Ed Silverman

Pharmalittle: Covid-19 vaccine makers push EU for liability protections; pharma plans counteroffer to Trump

Pharmalot By Ed Silverman

U.S. authorities charge Teva in generic price-fixing probe

Pharmalot By Ed Silverman

Cardinal Health is accused of running a ‘rent-a-vet’ scheme to win government contracts

Pharmalot By Ed Silverman

Pharmalittle: Hahn apologizes for statistical blunder; Fauci warns of approving a Covid-19 vaccine too soon

Pharmalot By Ed Silverman

Sun Pharma unit to pay $21 million for giving docs false instructions for a skin treatment

Pharmalot By Ed Silverman

Pharmacists say they tell patients about physical changes to pills, but consumers say that isn’t always the case

Pharmalot By Ed Silverman

Urged on by scientists, NIH will study Gilead’s remdesivir-like compound against Covid-19

Pharmalot By Ed Silverman

Pharmalittle: FDA decision to OK Covid-19 plasma prompts skepticism; will Trump fast track AstraZeneca vaccine?

The Pharmalot View By Ed Silverman

FDA commissioner needs to push back and tell Trump the agency is not part of the ‘deep state’

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot By Ed Silverman

Pharmalittle: FDA official would resign if agency pressured to OK Covid-19 vaccine; J&J plans huge vaccine trial

Pharmalot By Ed Silverman

Drug makers seek to curtail discounts paid to hospitals as part of a controversial federal program

Pharmalot By Ed Silverman

Boehringer to pay $379,000 to settle charges of wage discrimination against female employees

Pharmalot By Ed Silverman

Pharmalittle: Mail slowdown could limit access to drugs; CureVac nears a Covid-19 vaccine deal with Europe

Pharmalot By Ed Silverman

After FDA rejection of a key drug, is Gilead still a turnaround story?

Pharmalot By Ed Silverman

Pharmalittle: FDA surprises BioMarin and Gilead by rejecting key drugs; J&J pays $6.5 billion to buy Momenta

Pharmalot By Ed Silverman

Federal prosecutors allege Teva used charities to pay kickbacks to Medicare patients

Pharmalot By Ed Silverman

FDA finalizes penalties for clinical trial sponsors that don’t share data, but critics say they fall short

Pharmalot By Ed Silverman

Pharmalittle: Trump touts an unproven salve for Covid-19; states seek big bucks to settle opioid suits

Pharmalot By Ed Silverman

Opioid prescriptions written for Medicare Part D beneficiaries continues to drop

Pharmalot By Ed Silverman

Pharmalittle: U.S. ties Covid-19 vaccine payments to milestones; Sanofi spends $3.7 billion for Principia and an MS drug

Pharmalot By Ed Silverman

Medicaid beneficiaries sue Texas health agency for restricting access to hepatitis C medicines

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot By Ed Silverman

Pharmalittle: Governments race to acquire Covid-19 vaccines; top Russian doctor quits over vaccine ethics

Pharmalot By Ed Silverman

Doctors say antibiotic resistance is an issue — but most say they’re not part of the problem